BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24077685)

  • 1. Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.
    Wiener L; Baird K; Crum C; Powers K; Carpenter P; Baker KS; MacMillan ML; Nemecek E; Lai JS; Mitchell SA; Jacobsohn DA
    Support Care Cancer; 2014 Feb; 22(2):295-305. PubMed ID: 24077685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
    Merkel EC; Mitchell SA; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
    Fraser CJ; Bhatia S; Ness K; Carter A; Francisco L; Arora M; Parker P; Forman S; Weisdorf D; Gurney JG; Baker KS
    Blood; 2006 Oct; 108(8):2867-73. PubMed ID: 16788100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
    Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
    J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study.
    Mitchell SA; Hunter R; Fry A; Pavletic SZ; Widemann BC; Wiener L
    Front Psychol; 2023; 14():1243005. PubMed ID: 38259542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study.
    Lawitschka A; Güclü ED; Varni JW; Putz M; Wolff D; Pavletic S; Greinix H; Peters C; Felder-Puig R
    Bone Marrow Transplant; 2014 Aug; 49(8):1093-7. PubMed ID: 24820217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
    Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for disagreement between proxy-report and self-report rating of symptoms in children receiving cancer therapies.
    Tomlinson D; Plenert E; Dadzie G; Loves R; Cook S; Schechter T; Dupuis LL; Sung L
    Support Care Cancer; 2021 Jul; 29(7):4165-4170. PubMed ID: 33404808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental emotional functioning declines with occurrence of clinical complications in pediatric hematopoietic stem cell transplant.
    Terrin N; Rodday AM; Tighiouart H; Chang G; Parsons SK;
    Support Care Cancer; 2013 Mar; 21(3):687-95. PubMed ID: 22936494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience.
    Teusink-Cross A; Davies SM; Grimley MS; Chandra S; Flannery A; Dandoy CE; Nelson AS; Marsh RA; Jacoby B; Lane A; Khandelwal P
    Pediatr Transplant; 2020 May; 24(3):e13692. PubMed ID: 32202691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
    Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
    Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation.
    Harris BA; Berger AM; Mitchell SA; Steinberg SM; Baker KL; Handel DL; Bolle JL; Bush EG; Avila D; Pavletic SZ
    J Support Oncol; 2010; 8(3):119-25. PubMed ID: 20552925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
    Lee Sk; Cook EF; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Complications of Chronic Graft-Versus-Host Disease.
    Fall-Dickson JM; Pavletic SZ; Mays JW; Schubert MM
    J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Lertkovit O; Anurathapan U; Hongeng S; Thokanit NS; Pakakasama S
    Int J Hematol; 2021 Apr; 113(4):556-565. PubMed ID: 33385291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).
    Mitchell SA; Leidy NK; Mooney KH; Dudley WN; Beck SL; LaStayo PC; Cowen EW; Palit P; Comis LE; Krumlauf MC; Avila DN; Atlam N; Fowler DH; Pavletic SZ
    Bone Marrow Transplant; 2010 Apr; 45(4):762-9. PubMed ID: 19784078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment.
    Smith Knutsson E; Björk Y; Broman AK; Helström L; Nicklasson M; Brune M; Sundfeldt K
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1122-1129. PubMed ID: 29752810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.